Abstract:ABSTRACT Candida auris is an emerging yeast pathogen of major concern because of its ability to cause hospital outbreaks of invasive candidiasis and to develop resistance to antifungal drugs. A majority of C. auris isolates are resistant to fluconazole, an azole drug used for the treatment of invasive candidiasis. Mechanisms of azole resistance are multiple, including mutations in the target gene ERG11 and activation of the transcription factors Tac1b and Mrr1, which control the drug transporters Cdr1 and Mdr1, respectively. We investigated the role of the transcription factor Upc2, which is known to regulate the ergosterol biosynthesis pathway and azole resistance in other Candida spp. Genetic deletion and hyperactivation of Upc2 by epitope tagging in C. auris resulted in drastic increases and decreases in susceptibility to azoles, respectively. This effect was conserved in strains with genetic hyperactivation of Tac1b or Mrr1. Reverse transcription PCR analyses showed that Upc2 regulates ERG11 expression and also activates the Mrr1/Mdr1 pathway. We showed that upregulation of MDR1 by Upc2 could occur independently from Mrr1. The impact of UPC2 deletion on MDR1 expression and azole susceptibility in a hyperactive Mrr1 background was stronger than that of MRR1 deletion in a hyperactive Upc2 background. While Upc2 hyperactivation resulted in a significant increase in the expression of TAC1b , CDR1 expression remained unchanged. Taken together, our results showed that Upc2 is crucial for azole resistance in C. auris , via regulation of the ergosterol biosynthesis pathway and activation of the Mrr1/Mdr1 pathway. Notably, Upc2 is a very potent and direct activator of Mdr1. IMPORTANCE Candida auris is a yeast of major medical importance causing nosocomial outbreaks of invasive candidiasis. Its ability to develop resistance to antifungal drugs, in particular to azoles (e.g., fluconazole), is concerning. Understanding the mechanisms of azole resistance in C. auris is important and may help in identifying novel antifungal targets. This study shows the key role of the transcription factor Upc2 in azole resistance of C. auris and shows that this effect is mediated via different pathways, including the regulation of ergosterol biosynthesis and also the direct upregulation of the drug transporter Mdr1.

The Role of UPC2 Gene in Azole-Resistant Candida Tropicalis

Upc2-mediated mechanisms of azole resistance in Candida auris

Mechanisms of Azole Resistance in 52 Clinical Isolates of Candida Tropicalis in China.

[Molecular Mechanisms of Fluconazole Resistance in Clinical Isolates of Candida Glabrata].

RTA2, a novel gene involved in azole resistance in Candida albicans.

ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates

Hotspot Mutations and Genomic Expansion of ERG11 Are Major Mechanisms of Azole Resistance in Environmental and Human Commensal Isolates of Candida Tropicalis.

Mutations in Transcription Factor Mrr2p Contribute to Fluconazole Resistance in Clinical Isolates of Candida Albicans

MDR1 Overexpression Combined with ERG11 Mutations Induce High-Level Fluconazole Resistance in Candida Tropicalis Clinical Isolates.

Erg11 Mutations Associated with Azole Resistance in Clinical Isolates of Candida Albicans.

Study on mechanisms of zole-resistance of clinical Candida glabrata isolates

Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis

Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris

Erg 11 mutations associated with azole resistance in clinical isolates of Candida albicans Running title : Erg 11 mutations in Candida albicans

ABC Transporters Coupled with the Elevated Ergosterol Contents Contribute to the Azole Resistance and Amphotericin B Susceptibility

Mechanisms of Fluconazole Resistance in Clinical and Experimental Induced Isolates of Candida Glabrata

cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients

Identification of Essential Genes and Fluconazole Susceptibility Genes in Candida glabrata by Profiling Hermes Transposon Insertions

Analysis of ERG11 gene mutations in fluconazole-resistant Candida glabrata strains

Induction of Fluconazole Resistance in Candida Glabrata and Candida Parapsilosis in Vitro and Corresponding Mechanism

Detection of overexpression of genes encoding target enzyme and efflux pumps in fluconazole-resistant Candida albicans